Syed E. Abidi, Ph.D. has over 30 years of experience in pharmaceutical formulation development and is an original founding member of Pii. Dr. Abidi has extensive experience in dosage form development, including capsules, tablets, modified-release tablets, suspensions, solutions, small volume parenterals, suppositories, creams, ointments, gels, inhalation aerosols and transdermals. He also has experience with pre-approval inspection preparation and with the scale-up and launch of major pharmaceutical products (both prescription and OTC).
Prior to joining Pii, Dr. Abidi served as the Vice President of American Drug Development, Inc. from 1994 to 1995, where he was responsible for research and development activities. He also worked as the Director of Pharmaceutics at Hercon Laboratories, as a Principal Scientist for Applied Analytical, Inc., and as a Senior Scientist for Schering-Plough Pharmaceuticals.
Dr. Abidi earned his B.S. in Pharmacy from Karachi University in Pakistan in 1975, and his M.S. and Ph.D. in Pharmaceutics from the University of Mississippi in 1977.
Kurt Nielsen joined Pii in 2019 as President and CEO.
Dr. Nielsen is a seasoned pharmaceutical executive with over 20 years of diverse experience, most recently as the President of Lupin Somerset, responsible for all its generic and branded products. Prior to Lupin, he held the post of Vice President, U.S. Development, Portfolio and Launch Management at Sandoz Inc., where he was accountable for the U.S. development of generic, OTC and specialty brand products. Dr. Nielsen has also held positions at Catalent, where he was Senior Vice President of R&D and Chief Technology Officer, and URL Pharma where he was the Executive Vice President, Pharmaceuticals.
PJ joined Pii in late 2019 as Head of Commercial and Corporate Development, with 17 years of experience in the pharmaceutical industry.
PJ formerly served as an Account Manager at Johnson Matthey Inc., a leading provider of active pharmaceutical ingredients to both generic and brand companies. Prior to Johnson Matthey, PJ held BD positions with Advanced Bioscience Laboratories (CMO for biologics, vaccines and protein therapeutics) and SGS Analytical Services. He also served at the Regulatory and Quality Manager overseeing Investigator Initiated IND studies out of the Cleveland Clinic Taussig Cancer Center overseeing over 50 IND studies. PJ began his career as a quality control scientist and also held quality assurance and account management roles at Ben Venue Laboratories.
PJ earned his bachelors in Biology from Case Western Reserve University, and Masters in Business from Baldwin Wallace University.
Mr. Krishnan has over 25 years of experience in global supply chain operations & quality, customer fulfillment, global procurement and general management roles within the pharmaceutical, biologics, contract manufacturing (CDMO), contract research (CRO) and medical device industries. His most recent position was with Frontage Laboratories, where he served as Senior Vice President of Global Operations. He has also worked for Catalent Pharma Solutions & GE Healthcare wherein Mr. Krishnan held several global leadership positions in operations, supply chain, procurement and operational excellence. Throughout his career, Mr. Krishnan’s success has been driven by building high performing leadership teams and driving sustainable business transformations across the network.
Mr. Krishnan holds a bachelor’s degree in mechanical engineering from Bangalore University. He is also a Lean Six Sigma Master Black Belt.
Monique Mendoza joined Pii in 2017 as the Director, Quality Systems. Monique has over 20 years of experience in the pharmaceutical/biotechnology industry.
Prior to joining Pii, Monique served as Director of Quality for Dynavax Technologies both domestically and internationally. Monique also worked for Bayer Healthcare for over 15 years with increasing responsibilities in both Manufacturing and QA.
Monique earned her B.S. from the University of the Pacific.
Ken Lavin joined Pii in 2018 as the Senior Director, Quality Assurance. Ken has over 30 years of experience in the pharmaceutical industry.
Ken previously served as the Senior Director, Global Quality, Operational and Regulatory Compliance for Teva pharmaceuticals. Ken has held numerous roles of increasing responsibility in the QA area prior to joining Pii.
Ken earned a B.S. in Biology at Wilkes College and M.S. in Pharmaceutical Quality and Regulatory Affairs at Temple University.
John joined Pii in June 2018 as Chief Financial Officer.
Prior to Pii, John was Managing Director and Chief Operating Officer of Motir DuSable Power Investments, a renewable energy company focused on Sub-Saharan Africa. In earlier years he served in CFO roles in the technology, printing and plastics industries and began his career at Deloitte.
He is a CPA and has an M.B.A. and B.A. from Loyola University (Baltimore).
Sheryl Basile joined Pii in January of 2020 as Vice President of Human Resources
Sheryl has over 20 years of human resources experience including Halo Pharma where she led the HR function and most recently as Director of HR for Lupin Pharmaceutical’s Somerset site. Sheryl brings broad human resource experience with a business focus and partnership skills including Talent Management, Coaching, Employee Relations, Immigration, Performance Management, and Compensation Analysis.
Sheryl graduated from Lafayette College with a B.A. in Sociology.
Kevin Kelly joined Pii in September 2019. Kevin joined the Pii team with over twenty years of Sales Experience in the Pharmaceutical Manufacturing industry.
As the Head of Sales, Kevin works closely with the scientists and leaders of Pii to drive successful projects. With his industry knowledge, Kevin is able to specialize in challenging projects and manufacturing processes. His specialties include formulation development, CTM manufacture, analytical method development and validation, and process development.
Kevin graduated from Drexel University with a Bachelor of Science in Business Administration and Marketing.
Shawn Watson joined Pii in July, 2020 and is responsible for all product development, including sterile, non-sterile, oral, and topical dosage forms, as well as analytical methods development.
Shawn has over twenty years of leadership experience in the pharmaceutical industry in specialty, generic and contract development and manufacturing organizations (CDMOs). His wealth of knowledge spans Research and Development, Quality, and Technical Services.
Prior to joining Pii, he served as the Vice President of Quality and Laboratory Operations at Lupin Pharmaceuticals, Vice President of Compliance at Sigmapharm Laboratories, and Supervisor of Analytical R&D at Teva Pharmaceuticals. Additionally, he has held a variety of other key positions including Vice President of Quality, Senior Director of Chemistry & Manufacturing services, and Senior Manager of Analytical Research and Development. Shawn’s passion for working in the pharmaceutical industry began with his very first job as a quality control chemist with a CDMO and included work with Pii.
Shawn earned a Masters of Business Administration from the Fox School of Business at Temple University, a Masters of Science in Chemistry from Villanova University, and a Bachelors of Science in Chemistry and Biology from Heidelberg University. He also obtained a six sigma green belt from Villanova University.
Vishnu Dwadasi is responsible for all aspects of project management, guiding Pii’s client projects from pre-clinical through full-scale manufacturing for a wide-range of oral-dose and parenteral formulations.
Prior to joining Pii, Vishnu led the R&D and lab informatics focus area within the Life Sciences practice of West Monroe Partners. Before his time at West Monroe Partners, he was a Business Development Director at BioDuro, leading CMC sales for the east coast. He also worked at Catalent Pharma Solutions and held several positions in operations, R&D, project management and business development. Vishnu is an alumni of Catalent’s prestigious Global Operations Leadership and Development (GOLD) program. Vishnu has extensive experience shepherding complex drug development programs from early clinical development to full-scale commercial manufacturing and distribution.
Vishnu earned an MBA from the Fuqua School of Business at Duke University and a B.S. in Health Sciences from Purdue University.